2017. Safety of subcutaneous immunotherapy with tyrosine-adsorbed house dust mite extracts in patients with allergic disease. Revista Alergia México. 64, 1 (Feb. 2017), 52–65. DOI:https://doi.org/10.29262/ram.v64i1.233.